Wolverine Trading, LLC Biotechnology

Wolverine Trading, LLC

  • $83.2 Billion
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
ABSI
Absci Corp
CALL
$120,000
48K N/A
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$120,000
37.9K
Q3 2022
New holding
SAVA
Cassava Sciences Inc
CALL
$112,000
74.7K
Q2 2024
Reduced 29.56%
ARCT
Arcturus Therapeutics Holdings Inc.
PUT
$110,000
10.4K
Q2 2021
Closed
LIFE
A Tyr Pharma Inc
CALL
$108,000
58.5K
Q1 2025
Added 140.42%
HUMA
Humacyte, Inc.
CALL
$103,000
60.6K
Q4 2024
Reduced 28.44%
EYPT
Eye Point Pharmaceuticals, Inc.
CALL
$102,000
19K
Q1 2025
New holding
VIR
Vir Biotechnology, Inc.
PUT
$97,000
15K
Q4 2024
New holding
INMB
Inmune Bio, Inc.
PUT
$96,000
12.4K
Q1 2025
New holding
ABUS
Arbutus Biopharma Corp
CALL
$93,000
26.7K
Q3 2022
Reduced 5.77%
EYPT
Eye Point Pharmaceuticals, Inc.
PUT
$88,000
16.4K
Q1 2025
New holding
RCKT
Rocket Pharmaceuticals, Inc.
PUT
$84,000
12.7K
Q4 2024
New holding
IOVA
Iovance Biotherapeutics, Inc.
PUT
$83,000
25.2K
Q1 2025
Reduced 32.57%
ABUS
Arbutus Biopharma Corp
PUT
$80,000
23.2K
Q3 2022
Reduced 5.77%
INMB
Inmune Bio, Inc.
CALL
$79,000
10.2K
Q1 2025
New holding
SGMO
Sangamo Therapeutics, Inc
CALL
$79,000
120K
Q1 2025
Added 25.92%
ELDN
Eledon Pharmaceuticals, Inc.
PUT
$71,000
21K
Q1 2025
New holding
CRDF
Cardiff Oncology, Inc.
PUT
$67,000
21.6K
Q4 2024
Reduced 16.57%
EDIT
Editas Medicine, Inc.
CALL
$65,000
56.2K
Q1 2025
Reduced 66.28%
HUMA
Humacyte, Inc.
PUT
$59,000
34.8K
Q4 2024
Reduced 28.44%
CRDF
Cardiff Oncology, Inc.
CALL
$55,000
17.6K
Q4 2024
Reduced 16.57%
DMAC
Dia Medica Therapeutics Inc.
CALL
$53,000
14.1K
Q2 2021
New holding
QSI
Quantum Si Inc
PUT
$53,000
44.6K
Q1 2025
Reduced 63.86%
MNKD
Mannkind Corp
PUT
$51,000
10.2K
Q1 2025
Reduced 17.89%
VNDA
Vanda Pharmaceuticals Inc.
PUT
$49,000
10.8K
Q4 2024
Reduced 13.39%
PGEN
Precigen, Inc.
CALL
$46,000
31.4K
Q1 2025
Added 122.62%
SAVA
Cassava Sciences Inc
PUT
$43,000
28.7K
Q2 2024
Reduced 29.56%
AVIR
Atea Pharmaceuticals, Inc.
PUT
$42,000
14.1K
Q1 2024
Added 52.54%
CRVS
Corvus Pharmaceuticals, Inc.
PUT
$42,000
13.3K
Q3 2022
New holding
SANA
Sana Biotechnology, Inc.
CALL
$38,000
22.8K N/A
LIFE
A Tyr Pharma Inc
PUT
$32,000
17.5K
Q1 2025
Added 140.42%
SGMO
Sangamo Therapeutics, Inc
PUT
$31,000
47.2K
Q1 2025
Added 25.92%
PLX
Protalix Bio Therapeutics, Inc.
CALL
$29,000
11.7K
Q2 2023
New holding
BMEA
Biomea Fusion, Inc.
PUT
$25,000
11.8K
Q1 2025
New holding
OCGN
Ocugen, Inc.
CALL
$25,000
35.6K
Q1 2024
New holding
VERU
Veru Inc.
PUT
$24,000
50K
Q1 2025
Added 26.09%
PGEN
Precigen, Inc.
PUT
$22,000
15K
Q1 2025
Added 122.62%
CHRS
Coherus Bio Sciences, Inc.
CALL
$21,000
26.3K
Q1 2025
New holding
GALT
Galectin Therapeutics Inc
PUT
$20,000
16.7K
Q2 2022
Reduced 24.75%
GOSS
Gossamer Bio, Inc.
CALL
$20,000
18.5K
Q4 2024
Added 73.89%
ATOS
Atossa Therapeutics, Inc.
CALL
$19,000
29.8K
Q1 2025
New holding
EDIT
Editas Medicine, Inc.
PUT
$18,000
15.6K
Q1 2025
Reduced 66.28%
GALT
Galectin Therapeutics Inc
CALL
$16,000
13.7K
Q2 2022
Reduced 24.75%
ATAI
Atai Life Sciences N.V.
CALL
$15,000
11.7K N/A
RVPH
Reviva Pharmaceuticals Holdings, Inc.
CALL
$13,000
14.1K
Q4 2024
New holding
LXRX
Lexicon Pharmaceuticals, Inc.
CALL
$11,000
25.9K
Q3 2024
New holding
NKTR
Nektar Therapeutics
CALL
$11,000
17.2K
Q1 2025
New holding
MCRB
Seres Therapeutics, Inc.
CALL
$7,000
10K
Q3 2024
Reduced 11.79%
APLT
Applied Therapeutics Inc.
CALL
$6,000
12.3K
Q4 2024
New holding
Filter Shares Options
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email